Study of serum tumor markers CEA, CA 15.3 and CA 27.29 as .
1. Int J Biol Markers. 1995 Jan-Mar;10(1):24-9. . Serum levels of CEA, CA 15.3 and CA 27.29 were measured during the follow-up of 499 breast cancer patients.
CA 27-29 in patients with breast cancer with pulmonary fibrosis. - NCBI
1. Clin Breast Cancer. 2008 Dec;8(6):538-40. doi: 10.3816/CBC.2008.n.067. . Measurement of CA 27-29 has been approved by the US Food and Drug.
The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma .
(1)Montreal General Hospital, McGill University, Department of Medicine, Que., Canada. In the past decade, considerable interest has arisen for defining the role of various tumor markers in the diagnosis of cancer. This cross-sectional study evaluates four breast cancer markers (CA 27-29, CA 15-3, . Publication Types:.
CA 27-29 - Adventist Health
Does this test have other names? Cancer antigen 27-29. What is this test? CA 27-29 is a blood test used to watch certain types of cancer. CA 27-29 is the name.
Concordance analysis of paired cancer antigen (CA) 15-3 and 27.29 .
Sep 19, 2017 . 1. Breast Cancer Res Treat. 2018 Jan;167(1):269-276. doi: . PURPOSE: Cancer antigens (CA) 15-3 and 27.29 are used in the clinical.